Model
Edge
Revance Therapeutics Inc.
0001848717
Filing Type
4
Filing Date
5/6/2021
Updated
5/7/21, 1:08 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership